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Omayma M Sabir1, Yassin M Al Hag2, Mohammed O H Gadour3. 
Abstract: 
Background: Portal Vein Thrombosis (PVT) is one of the most common causes of portal 
hypertension among children in Sudan. 
Objectives: To determine the incidence, aetiology and mode of presentation of PVT among 
children and find its relation to gastrointestinal bleeding in a Sudanese hospital. 
Methodology: This is a prospective hospital based study conducted at a tertiary care paediatric 
hospital in Khartoum, Sudan (Gaffer Ibn Oaf Specialized Children Hospital (GIO)). 350 children 
were diagnosed on clinical grounds (heamatemiss, splenomegaly) to have portal hypertension. After 
laboratory investigations (CBC, LFTs, coagulations profile and RFTs), abdominal sonography with 
Doppler, 275 patients turned to have portal vein thrombosis. Upper GI endoscopy was done for all 
patients and liver biopsy when indicated.  Data were analysed, discussed and conclusion were 
reached. 
Results: Out of 800 children presented with upper GI bleeding 350 were diagnosed as having 
esophageal varices bleeding due to portal hypertension (44%), out of these 250 (70%) children were 
found to have PVT as a cause of their portal hypertension, and another 25 children were diagnosed 
to have PVT without GI bleeding. Their ages ranged between 4 month and 16 years. Two hundred 
were males. Seventy five were below one year of age. History of risk factor for PVT was found 
only in 68 children. All the bleeders had sclerotherapy, band ligation or both beside propranolol and 
H2 blockers or PPI. Time for follow up was between 6 month and 4.5 years. 150 children cleared 
their varices with 4-6 cession of either sclerotherapy, banding or both, the rest of the children are 
still receiving sclerotherapy. Ten children received liver support for portal biliopathy, five children 
had splenectomy because of hypersplenism.  Four children died. Propranolol was stopped in 50 
children out of 150 children who cleared their varices after two years 
Conclusions: PVT in children is common in Sudanese children, and represents the second common 
cause of upper GI bleeding. Its aetiology is obscure in the majority of cases and more studies and 
facilities are needed to uncover the underlying cause. Simple clinical data, ultrasonography and 
upper GI endoscopy are quite adequate measures to reach accurate diagnosis. 
Combinations of endoscopic sclerotherapy and band ligations with propranolol are very effective in 
controlling the bleeding of the esophageal varices, though it has a remarkable effect on the quality 
of life of affected children. Thus appropriate medical alternative or surgical treatments are needed 
in order to reduce morbidity and mortality and improve the quality of life of these patients. 
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ortal Vein Thrombosis (PVT) is one of 
the most common causes of Portal 
Hypertension among children in   
Sudan 1. 
The incidence, aetiology, clinical 
manifestation, treatment modules and 
outcome were not studied before in Sudan. 
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To determine the incidence, aetiology and 
mode of presentation of PVT among children 
who presented to our Gastrointestinal (GI) 
unit at Gaffer Ibn Oaf Specialized Children 
Hospital (GIO) in Khartoum, during January 
2005-June 2010, and see how many of them  
presented with GI bleeding. Also we want to 
determine the management and out the 
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Patients and Method: This study was 
conducted at GIO Children Hospital, 
Khartoum, Sudan, which is the main tertiary 
care paediatric hospital and represents the 
only centre for established paediatric 
endoscopy unit in the country. Out of 5000 
children seen at our GI unit over the last five 
years, 275 were diagnosed to have PVT. 
Detailed history was obtained for all the 
children with special references to the risk 
factors (umbilical sepsis, cathetrization, and 
admission to SCABU, gastroenteritis and 
dehydration or septicaemia) and history of 
consanguinity were obtained. Their ages 
ranged between four month and 16 years. The 
diagnosis was made on clinical interpretation 
(heamatemiss, splenomegaly, 
portalbiliopathy), laboratory investigations 
(CBC, LFTs, coagulations profile and RFTs), 
abdominal sonography with Doppler, upper 
GI endoscopy and liver biopsy when 
indicated.  
We couldn't perform the haemophilic screen 
for technical reasons, we managed only to do 
it in two children on their family's expenses 
abroad and it was negative. 
Results: Out of 800 children presented with 
upper GI bleeding 350 were diagnosed as 
having oesophageal varices bleeding due to 
portal hypertension (PHT) (44%). Out of 
these 250 (70%) have PVT as a cause of their 
PHT. 100(30%) children have other causes. 
Another 25 children diagnosed with PVT who 
did not have GI bleeding, (10 children 
presented with hyper splenism, 10 with portal 
biliopathy and five presented with only 
splenomegaly). 
Two hundred children were males. Seventy 
five were below one year of age and they all 
presented with heamtemisis with or without 
splenomegaly. 
History of risk factors (umbilical sepsis, 
cathetrization, and admission to SCABU, 
gastroenteritis and dehydration or 
septicaemia) was found in 68 children and 
consanguinity in 75 children, and both in only 
40 children.  
Management was focused to treat 
complications and included primary and 
secondary prophylaxis against upper 
gastrointestinal bleeding (that resulted from 
the rupture esophageal varices). All the 
bleeders had sclerotherapy, band ligation or 
both beside propranolol and H2 blockers or 
PPI. 
Ten children received liver support for portal 
biliopathy, five children had splenectomy 
because of hypersplenism. None of those 
children had any form of portocaval shunt, 
nor other surgical interventions. 
Time for follow up was between 6 month-4.5 
years. 150 children cleared their varices with 
4-6 cession of either sclerotherapy, banding 
or both, the rest of the children are still 
receiving sclerotherapy. We lost two children 
in the hospital with severe upper GI bleeding 
and another two children with bleeding at 
home. 
Propranolol was stopped in 50 children out of 
150 children who cleared their varices after 
two years; they developed good porto-
systemic collaterals evident by 
ultrasonography and Doppler. 
Discussion
Similar to reports from elsewhere, the cause 
of PVT is not known in the majority (73%) of 
our patients2, 3.  
Detailed history revealed risk factors for PVT 
in around 27%, consanguinity in 40% and 
both in around 15%. Almost all the families 
couldn't afford to do the haemophilic screen 
apart from two children in whom the screen 
was done abroad and it was negative. 
However, in our patients, the low 
socioeconomic class as a separate risk factor 
or its association with umbilical sepsis, 
gastroentritis, dehydration and malnutrition 
might have contributed to that4. 
The main presenting symptom was upper 
gastrointestinal bleeding in 91% of the 
children which is consistent with the 
literature4, while splenomegaly was found in 
the majority of them, however, pancytopenia 
due to hyper splenism was found in only five 
children. Hepatopulmonary syndrome is rare 
in non-cirrhotic patients who have PVT, in 
line with that none of our patients had the 
syndrome5.  
Abdominal ultrasound was reported to have 
high sensitivity (94-100%) and specificity 
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(90-96%) in the diagnosis of PVT, upper GI 
endoscopy will support that and aid the 
management especially in bleeders2, 5. In 
concordance with that abdominal 
ultrasonography and upper GI endoscopy 
were able to suggest the diagnosis in almost 
all of our patients.  As expected LFTs were 
normal in the vast majority apart from only 
less than 1% in whom liver biopsies were 
performed and revealed periportal fibrosis 
and that goes with the literature3.  
Sclerotherapy combined with band ligations 
(when technically possible) were very 
effective in clearing the bleeding oesophageal 
varices electively6.  
Supporting that in 150 children, we managed 
to eradicate the varices after 4-6 intervention 
cessions, 6 weeks apart in average, and the 
patients were continued on prophylactic 
therapy. The rest are still receiving 
sclerotherapy cessions and continuing to 
receive propranolol. Propranolol was very 
effective as prophylaxis to prevent further re- 
bleeding7.  Fifty of the children who cleared 
the varices needed no more propranolol. 
This form of treatment, though safe and 
effective (with mortality of less than 0.1%)8-
11, affects the children life and family so 
adversely, with the amount of hospital 
admissions, the frequent endoscopic cessions 
and the medications they have to take. Most 
of the older children had become school 
leavers. 
The outcome of selective portocaval shunts 
seems to be quite encouraging12. The 
applicability of such technique in Sudan is not 
an option in the present time with the lack of 
trained paediatric vascular surgeons, and 
hence none of our patients had this procedure. 
Splenectomy was necessary in five children 
because of hypersplenism, though we noticed 
the degree of splenomegaly spontaneously 
decreased with time, propably indicating the 
development of porto systemic collaterals. 
This is consistent with the findings that 
childhood PVT bleeding tend to decrease in 
early adulthood13.  
Children who had biliopathy are on liver 
support and conservative support and 
management, though they all had their growth 
being compromised14.  
Mortality rate in non-cirrhotic variceal 
bleeders is not high3, going with that only 
four of our patients died because of bleeding. 
Although it has been postulated that the cause 
of growth retardation is due to chronic 
anemia, intestinal venous congestion leading 
to malabsorption syndrome, hepatic 
hypoperfusion resulting in hepatotrophic 
hormone deficiency2,15, 16, the reason why 
some of the children with PVT have their 
growth compromised while the others don’t 
seem to be affected remains a challenge that 
needs to be studied more!! 
Conclusions 
PVT in children is common in Sudanese 
children, and represents the second common 
cause of upper GI bleeding. Its aetiology is 
obscure in the majority of cases and more 
studies and facilities are needed to uncover 
the mysterious about it. Nevertheless, the 
common known risk factors and 
thrombophilic seem to contribute to a 
significant number. 
Simple clinical data, ultrasonography and 
upper GI endoscopy are quite adequate 
measures to reach accurate diagnosis. 
Combinations of endoscopic sclerotherapy 
and band ligations with propranolol are very 
effective in controlling the bleeding of the 
esophageal varices, though it has a 
remarkable effect on the quality of life of 
affected children. Thus appropriate alternative 
surgical treatments are needed in order to 
reduce morbidity and mortality and improve 
the quality of life of these patients. 
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